Article Sidebar
Published:
Mar 16, 2016Article Details
Copyright remains in the Author’s name. The work is licensed under a Creative Commons Attribution - Noncommercial Works License. Authors are required to complete and sign an Author Agreement form that outlines Author and Publisher rights and terms of publication. The Agreement form should be uploaded along with other submissions files and any submission will be considered incomplete without it [forthcoming].
Material submitted for publication in the SAMJ is accepted provided it has not been published or submitted for publication elsewhere. Please inform the editorial team if the main findings of your paper have been presented at a conference and published in abstract form, to avoid copyright infringement. The SAMJ does not hold itself responsible for statements made by the authors.
Previously published images
If an image/figure has been previously published, permission to reproduce or alter it must be obtained by the authors from the original publisher and the figure legend must give full credit to the original source. This credit should be accompanied by a letter indicating that permission to reproduce the image has been granted to the author/s. This letter should be uploaded as a supplementary file during submission.
Main Article Content
Willingness to participate in South African HIV vaccine trials - concerns of medical professionals in the Western Cape
Abstract
Objectives. To evaluate the willingness of medical doctors working at a tertiary hospital to participate in HIV vaccine trials, their perceptions ofpatients' willingness to participate, and the major reasons underlying these views.
Design. A self-administered, anonymous postal survey conducted in two rounds between May and July 2001.
Setting. A tertiary care hospital in the Western Cape.
Subjects. All medical doctors listed on the hospital's staff directory.
Outcome measures. Willingness to participate in, and to recruit patients into, HIV vaccine trials, and the reasons for this.
Results and conclusions. Of the 289 individuals surveyed, 80% stated either that they would not be willing to participate in HIV vaccine trials or that they were unsure about their participation. Meanwhile, 37% stated that they would be willing to recruit patients into vaccine trials. The most common concerns with trial participation were the possibility of vaccine-induced infection and the possibility of testing positive for antibodies to HIV. The surprisingly low level of willingness to participate in trials in this sample of medical professionals highlights the importance of preparatory work to overcome substantial barriers to HIV vaccine trial participation.
